Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Zotarolimus-Eluting Stent Versus Sirolimus-Eluting Stent and PacliTaxel-Eluting Stent for Coronary Lesions (ZEST)

This study has been completed.
Medtronic Vascular
Information provided by (Responsible Party):
Seung-Jung Park, CardioVascular Research Foundation, Korea Identifier:
First received: January 3, 2007
Last updated: August 20, 2012
Last verified: August 2012